Education
About Us
Working with TipRanks
Follow Us
Sofwave Medical Ltd. (IL:SOFW)
:SOFW
Top Page
Sofwave
(SOFW)
55Neutral
Sofwave (SOFW) vs. S&P 500 (SPY)
Market Cap
564.74M
Dividend YieldN/A
Average Volume (3M)17.84K
Price to Earnings (P/E)―
Beta (1Y)0.80
Revenue GrowthN/A
EPS GrowthN/A
CountryIL
Employees126
SectorHealthcare
Sector Strength57
IndustryMedical - Devices
Share Statistics
EPS (TTM)-0.46
Shares Outstanding35,230,370
10 Day Avg. Volume18,551
30 Day Avg. Volume17,837
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit11.27
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sofwave Business Overview & Revenue Model
Company DescriptionSofwave Medical Ltd. (SOFW) is a medical technology company specializing in non-invasive aesthetic treatments. The company operates within the beauty and healthcare sectors, focusing on developing and commercializing advanced ultrasound technology for skin rejuvenation and wrinkle reduction. Sofwave's flagship product, the Sofwave System, utilizes proprietary Synchronous Ultrasound Parallel Beam SUPERB technology to deliver effective, safe, and quick treatments that address fine lines and wrinkles.
How the Company Makes MoneySofwave generates revenue primarily through the sale of its ultrasound-based devices and associated consumables to medical professionals, clinics, and aesthetic centers. The company also earns income from service agreements, training, and support packages offered to practitioners using their technology. Additionally, Sofwave may engage in strategic partnerships with distributors and healthcare providers to expand its market reach and enhance sales. Revenue is further supported by ongoing research and development efforts to innovate and introduce new products within the aesthetic treatment market.
Sofwave Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 59.65M | 50.31M | 35.63M | 21.84M | 4.29M | Gross Profit |
| 45.34M | 37.48M | 26.33M | 16.24M | 2.63M | EBIT |
| -3.58M | -7.99M | -17.34M | -8.87M | -6.55M | EBITDA |
| -2.19M | -6.61M | -16.97M | -8.49M | -11.32M | Net Income Common Stockholders |
| -4.55M | -8.28M | -19.53M | -6.83M | -11.69M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 21.62M | 24.42M | 32.01M | 46.21M | 2.64M | Total Assets |
| 43.03M | 43.54M | 46.08M | 60.77M | 4.82M | Total Debt |
| 1.40M | 1.33M | 1.92M | 2.37M | 78.00K | Net Debt |
| -20.22M | -23.09M | -30.08M | -43.84M | -2.57M | Total Liabilities |
| 18.50M | 17.19M | 13.74M | 14.07M | 3.29M | Stockholders Equity |
| 24.53M | 26.34M | 32.34M | 46.70M | 1.53M |
| Cash Flow | Free Cash Flow | |||
| -2.67M | -6.71M | -11.14M | -2.92M | -5.07M | Operating Cash Flow |
| -2.40M | -6.31M | -10.69M | -2.10M | -4.80M | Investing Cash Flow |
| 254.00K | 409.00K | -260.00K | -982.00K | -263.00K | Financing Cash Flow |
| -620.00K | -1.72M | -1.35M | 46.64M | 1.99M |
Sofwave Technical Analysis
Neutral
1873.00
Price Trends
1626.48
Negative
1631.70
Negative
1695.51
Negative
Market Momentum
-19.27
Negative
52.04
Neutral
65.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:SOFW, the sentiment is Neutral. The current price of 1873 is above the 20-day moving average (MA) of 1519.55, above the 50-day MA of 1626.48, and above the 200-day MA of 1695.51, indicating a neutral trend. The MACD of -19.27 indicates Negative momentum. The RSI at 52.04 is Neutral, neither overbought nor oversold. The STOCH value of 65.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:SOFW.
Sofwave Peers Comparison
Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Performance Comparison
IL:SOFW
Sofwave
1,659.00
-89.00
-5.09%
SPNS
Sapiens
28.17
-1.93
-6.41%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.